M & As this week: BriaCell Therapeutics, Lentigen Technology

BriaCell Therapeutics plans to acquire Sapientia Pharmaceuticals through its subsidiary BriaCell Therapeutics (BriaCell USA).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals